CAPItello-292 Phase 3: An open-label, randomized study of capivasertib, fulvestrant, and investigator's choice of CDK4/6 inhibitor (palbociclib or ribociclib) in HR+/HER2- advanced breast cancer
Capivasertib;Fulvestrant;Palbociclib;Ribociclib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: CAPItello-292 Phase 3: An open-label, randomized study of capivasertib, fulvestrant, and investigator's choice of CDK4/6 inhibitor (palbociclib or ribociclib) in HR+/HER2- advanced breast cancer ### Output: Capivasertib;Fulvestrant;Palbociclib;Ribociclib